Source: Autobound Signal API · 109 signals tracked for Abbott · updated
Get Abbott's live signals in Claude or ChatGPT, or by API
What changed at Abbott this week? Use Autobound signals for abbott.com.Abbott launched SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test, alongside receiving FDA approval for Libre Duo and TactiFlex Duo.
Filing excerpt
In September, Abbott launched SimpleScreen™ CRC, an FDA-approved, blood-based colorectal cancer screening test for adults age 45 and older who are at average risk for the disease.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-8kproductLaunchGet every 8-K signal for Abbott and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/5898d528-fad5-4383-956e-96d9ef2d956b returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.
{
"signal_id": "5898d528-fad5-4383-956e-96d9ef2d956b",
"signal_type": "sec-8k",
"signal_subtype": "productLaunch",
"detected_at": "2026-10-27T08:04:09.17+00:00",
"company": {
"name": "Abbott",
"domain": "abbott.com"
},
"data": {
"detail": "Abbott launched SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test, alongside receiving FDA approval for Libre Duo and TactiFlex Duo. Sales teams supporting clinical diagnostics and medical commercialization may find expanded partnership opportunities around these rollouts.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "Abbott launches SimpleScreen CRC and multiple FDA-approved medical devices in Q3 2026",
"excerpts": "In September, Abbott launched SimpleScreen™ CRC, an FDA-approved, blood-based colorectal cancer screening test for adults age 45 and older who are at average risk for the disease.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/abt-20261021.htm",
"filing_date": "2026-10-21",
"filing_year": 2026,
"fiscal_year_end": "10/21",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
],
"technologies_mentioned": [
"blood-based colorectal cancer screening test"
]
}
}
curl https://signals.autobound.ai/v1/signals/5898d528-fad5-4383-956e-96d9ef2d956b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbott.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.